Intelligent Bio Solutions Inc. (INBS) Balance Sheet
INBS balance sheet, FY2026
June 30, 2026 · U.S. dollars$11.9M assets = $6.7M liabilities + $5.3M equity
Both columns are drawn to the same scale: what INBS owns equals what it owes plus shareholders’ equity. Hover a block for its value.
INBS financial health
Descriptive bands, not a rating. Fiscal FY2026.
INBS balance sheet trends, FY2017–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $667,227FY2017 | $11.9MFY2026 | +37.8%/yr | |
| Total liabilities | $6.6MFY2017 | $6.7MFY2026 | +0.1%/yr | |
| Shareholders’ equity | −$5.9MFY2017 | $5.5MFY2026 | — | |
| Cash & short-term investments | $56,033FY2017 | $4.0MFY2026 | +60.6%/yr | |
| Total debt | $3.5MFY2017 | $1.8MFY2026 | −7.1%/yr | |
| Net cash (debt) | −$3.5MFY2017 | $2.2MFY2026 | +$5.7M | |
| Working capital | −$5.9MFY2017 | $2.2MFY2026 | +$8.1M | |
| Book value per share | $0.45FY2022 | $3.74FY2026 | +70.2%/yr | |
| Current ratio | 0.10FY2017 | 1.44FY2026 | +1.34 | |
| Debt / equity | 0.01FY2021 | 0.33FY2026 | +0.32 | |
| Shares outstanding | 14.7MFY2022 | 1.5MFY2026 | −43.7%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
INBS assets
INBS liabilities and equity
INBS debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
INBS balance sheet
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $4.0M | $1.0M | $6.3M | $1.5M | $8.2M | $12.6M | $427,273 | $197,940 | $418,420 | $56,033 |
| Cash & equivalents | $4.0M | $1.0M | $6.3M | $1.5M | $8.2M | $12.6M | $427,273 | $197,940 | $418,420 | $56,033 |
| Short-term investments | — | — | — | $46,602 | — | — | — | — | — | — |
| Receivables | $848,464 | $1.6M | $978,348 | $833,164 | $2.5M | $2.1M | $19,593 | $94,504 | $36,481 | $0 |
| Inventory | $418,577 | $635,215 | $777,537 | $979,907 | $0 | −$3.2M | $1.9M | $2.0M | $2.0M | $0 |
| Other current assets | $1.8M | $884,389 | $474,260 | $512,246 | $163,127 | $6.7M | $0 | $53,837 | $12,000 | $611,194 |
| Total current assets | $7.1M | $4.1M | $8.5M | $3.9M | $10.9M | $18.2M | $476,335 | $2.3M | $2.5M | $667,227 |
| Property, plant & equipment (net) | $2.0M | $320,845 | $872,594 | $1.2M | $391,408 | $0 | $0 | $0 | $0 | $0 |
| Goodwill & intangible assets | $2.8M | $3.8M | $4.4M | $5.3M | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $135,692 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $1.1M | $3.7M | $1.9M | $0 | $0 | $0 |
| Total assets | $11.9M | $8.2M | $13.8M | $10.4M | $12.4M | $21.9M | $2.5M | $2.3M | $2.5M | $667,227 |
| Liabilities | ||||||||||
| Accounts payable | $712,449 | $897,258 | $602,337 | $1.2M | $715,902 | $1.4M | $483,576 | $849,720 | $167,466 | $339,174 |
| Short-term debt | $147,005 | $281,805 | $1.1M | $800,105 | — | $137,812 | $5.1M | $5.1M | $4.8M | $3.5M |
| Deferred revenue | — | $2.2M | $2.5M | $2.3M | $2.8M | $2.1M | — | — | — | — |
| Total current liabilities | $4.9M | $5.4M | $5.5M | $5.9M | $4.7M | $3.7M | $7.7M | $6.3M | $5.6M | $6.6M |
| Long-term debt | $0 | $0 | $0 | $402,862 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $1.8M | $84,659 | $356,158 | $579,612 | $0 | — | — | — | — | — |
| Other long-term liabilities | $1.7M | $84,921 | $144,939 | $381,067 | $1.1M | $3.2M | $5.6M | $6.0M | $5.0M | $3.9M |
| Total liabilities | $6.7M | $5.4M | $5.6M | $6.7M | $5.8M | $6.9M | $7.7M | $6.3M | $5.6M | $6.6M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $29,056 | $73,230 | $34,557 | $23,304 | $148,899 | $135,821 | $86,300 | $1.9M | $1 | $1 |
| Retained earnings (deficit) | −$75.0M | −$62.5M | −$52.0M | −$41.8M | −$31.2M | −$22.9M | −$15.8M | −$12.7M | −$5.3M | −$311,672 |
| Accumulated other comprehensive income | −$546,186 | −$327,944 | −$712,614 | −$575,496 | −$788,135 | −$661,259 | −$363,951 | −$216,870 | $571,105 | $2,717 |
| Minority interest | −$220,009 | −$182,312 | −$146,159 | −$111,986 | — | — | — | — | — | — |
| Total shareholders' equity | $5.5M | $3.0M | $8.3M | $3.8M | $6.5M | $15.1M | −$5.2M | −$4.6M | −$4.4M | −$5.9M |
| Key figures | ||||||||||
| Total debt | $1.8M | $281,805 | $1.1M | $1.9M | — | $137,812 | $5.1M | $5.1M | $4.8M | $3.5M |
| Net cash (debt) | $2.2M | $738,104 | $5.2M | −$378,053 | — | $12.4M | −$4.7M | −$4.9M | −$4.4M | −$3.5M |
| Working capital | $2.2M | −$1.2M | $3.1M | −$2.0M | $6.2M | $14.5M | −$7.2M | −$4.0M | −$3.1M | −$5.9M |
| Tangible book value | $2.7M | −$794,183 | $4.0M | −$1.5M | $6.5M | $15.1M | −$5.2M | −$4.6M | −$4.4M | −$5.9M |
| Book value per share | $3.74 | — | — | — | $0.45 | — | — | — | — | — |
| Shares outstanding | 1.5M | — | — | — | 14.7M | — | — | — | — | — |
| Current ratio | 1.44 | 0.77 | 1.57 | 0.66 | 2.33 | 4.94 | 0.06 | 0.37 | 0.45 | 0.10 |
| Quick ratio | 0.98 | 0.49 | 1.34 | 0.40 | 2.30 | 3.98 | 0.06 | 0.05 | 0.08 | 0.01 |
| Debt / equity | 0.33 | 0.09 | 0.14 | 0.50 | — | 0.01 | — | — | — | — |
| Equity / assets | 46.1% | 36.3% | 60.5% | 36.7% | 53.0% | 68.9% | −209.5% | −198.2% | −175.3% | −886.1% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $4.0M | $6.9M | $740,371 | $1.7M | $1.0M | $2.8M | $2.2M | $6.4M | $6.3M | $9.4M | $1.1M | $1.7M |
| Cash & equivalents | $4.0M | $6.9M | $740,371 | $1.7M | $1.0M | $2.8M | $2.2M | $6.3M | $6.3M | $9.4M | $1.1M | $1.5M |
| Short-term investments | — | — | — | — | — | — | — | $111,189 | — | — | — | $118,193 |
| Receivables | $848,464 | $1.4M | $10.4M | $1.6M | $1.6M | $1.0M | $641,767 | $429,704 | $978,348 | $764,117 | $552,001 | $293,861 |
| Inventory | $418,577 | $597,469 | $590,246 | $628,177 | $635,215 | $683,488 | $701,280 | $777,537 | $777,537 | $877,905 | $942,050 | $979,907 |
| Other current assets | $1.8M | $843,090 | $480,133 | $554,202 | $884,389 | $585,456 | $476,270 | $911,715 | $474,260 | $481,046 | $331,601 | $933,356 |
| Total current assets | $7.1M | $9.7M | $12.2M | $4.5M | $4.1M | $5.1M | $4.1M | $8.5M | $8.5M | $11.5M | $2.9M | $3.9M |
| Property, plant & equipment (net) | $2.0M | $2.1M | $2.2M | $2.1M | $320,845 | $673,256 | $719,862 | $872,594 | $872,594 | $925,032 | $1.0M | $1.2M |
| Goodwill & intangible assets | $2.8M | $3.0M | $3.3M | $3.5M | $3.8M | $3.8M | $3.9M | $4.4M | $4.4M | $4.6M | $4.9M | $5.3M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total assets | $11.9M | $14.9M | $17.7M | $10.0M | $8.2M | $9.6M | $8.7M | $13.8M | $13.8M | $17.0M | $8.8M | $10.4M |
| Liabilities | ||||||||||||
| Accounts payable | $712,449 | $2.0M | $4.3M | $4.0M | $897,258 | $1.3M | $1.1M | $602,337 | $602,337 | $2.1M | $1.8M | $1.2M |
| Short-term debt | $147,005 | $388,746 | $395,518 | $502,588 | $281,805 | $507,478 | $611,480 | $790,116 | $1.1M | $628,890 | $621,286 | $576,658 |
| Deferred revenue | — | — | — | — | $2.2M | $2.3M | $2.3M | $2.6M | $2.5M | $2.3M | $2.4M | $2.2M |
| Total current liabilities | $4.9M | $4.6M | $5.1M | $5.1M | $5.4M | $4.6M | $4.4M | $5.5M | $5.5M | $5.7M | $5.2M | $5.9M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $150,426 | $230,969 | $306,234 |
| Lease obligations | $1.8M | $1.8M | $1.9M | $1.8M | $84,659 | $155,026 | $220,480 | $309,676 | $356,158 | $414,539 | $479,461 | $511,442 |
| Other long-term liabilities | $1.7M | $1.5M | $1.6M | $1.5M | $84,921 | $76,376 | $77,818 | $144,939 | $144,939 | $184,448 | $258,703 | $477,695 |
| Total liabilities | $6.7M | $6.1M | $6.8M | $6.6M | $5.4M | $4.6M | $4.5M | $5.6M | $5.6M | $6.0M | $5.7M | $6.7M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $29,056 | $20,012 | $12,384 | $90,985 | $73,230 | $67,941 | $48,068 | $34,557 | $34,557 | $29,135 | $14,760 | $1,942 |
| Retained earnings (deficit) | −$75.0M | −$71.1M | −$68.2M | −$65.5M | −$62.5M | −$59.4M | −$56.9M | −$52.0M | −$52.0M | −$49.2M | −$46.2M | −$41.8M |
| Accumulated other comprehensive income | −$546,186 | −$499,710 | −$266,079 | −$279,228 | −$327,944 | −$523,417 | −$639,424 | −$712,613 | −$712,614 | −$662,405 | −$518,379 | −$575,496 |
| Minority interest | −$220,009 | −$210,249 | −$203,321 | −$194,298 | −$182,312 | — | — | — | — | — | — | — |
| Total shareholders' equity | $5.5M | $9.0M | $11.1M | $3.6M | $3.0M | $5.1M | $4.4M | $8.3M | $8.3M | $11.1M | $3.3M | $3.8M |
| Key figures | ||||||||||||
| Total debt | $1.8M | $1.8M | $3.5M | $2.0M | $281,805 | $511,182 | $626,015 | $871,440 | $1.1M | $933,478 | $1.1M | $1.3M |
| Net cash (debt) | $2.2M | $5.0M | −$2.7M | −$291,748 | $738,104 | $2.3M | $1.6M | $5.5M | $5.2M | $8.5M | $38,039 | $319,752 |
| Working capital | $2.2M | $5.1M | $7.0M | −$577,705 | −$1.2M | $542,946 | −$341,243 | $3.1M | $3.1M | $5.8M | −$2.2M | −$2.0M |
| Tangible book value | $2.7M | $6.0M | $7.8M | $147,924 | −$794,183 | $1.3M | $463,453 | $4.0M | $4.0M | $6.5M | −$1.6M | −$1.5M |
| Book value per share | $1.90 | $5.62 | $11.67 | $4.24 | — | — | — | — | — | — | — | — |
| Shares outstanding | 2.9M | 1.6M | 951K | 855K | — | — | — | — | — | — | — | — |
| Current ratio | 1.44 | 2.11 | 2.37 | 0.89 | 0.77 | 1.12 | 0.92 | 1.57 | 1.57 | 2.02 | 0.57 | 0.66 |
| Quick ratio | 0.98 | 1.80 | 2.17 | 0.65 | 0.49 | 0.84 | 0.66 | 1.26 | 1.34 | 1.78 | 0.32 | 0.33 |
| Debt / equity | 0.33 | 0.21 | 0.31 | 0.54 | 0.09 | 0.10 | 0.14 | 0.10 | 0.14 | 0.08 | 0.33 | 0.35 |
| Equity / assets | 46.1% | 60.3% | 62.8% | 36.1% | 36.3% | 53.4% | 50.3% | 60.5% | 60.5% | 65.3% | 37.2% | 36.7% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed August 19, 2026); data from EODHD.
INBS financial position
At the end of fiscal 2026 (June 30, 2026), Intelligent Bio Solutions had total assets of $11.9 million (up 44.8% from a year earlier), total liabilities of $6.7 million and shareholders' equity of $5.5 million. It held $4.0 million in cash and short-term investments against $1.8 million of debt, a net cash position of $2.2 million. Its current ratio was 1.44.
Related: INBS income statement, INBS cash flow statement, INBS key metrics. See the INBS stock overview for the latest quote and news.
INBS balance sheet FAQ
What are Intelligent Bio Solutions's total assets?
Intelligent Bio Solutions reported total assets of $11.9 million at the end of fiscal 2026 (June 30, 2026), compared with $8.2 million a year earlier.
How much debt does Intelligent Bio Solutions have?
Intelligent Bio Solutions had $1.8 million of total debt at the end of fiscal 2026, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.33.
How much cash does Intelligent Bio Solutions have?
Intelligent Bio Solutions held $4.0 million in cash and short-term investments at the end of fiscal 2026; with $1.8 million of debt that is net cash of $2.2 million.
What is Intelligent Bio Solutions's book value?
Intelligent Bio Solutions's shareholders' equity (book value) was $5.5 million at the end of fiscal 2026, or $3.74 per share.
What is Intelligent Bio Solutions's current ratio?
Intelligent Bio Solutions had current assets of $7.1 million and current liabilities of $4.9 million, a current ratio of 1.44 (it can cover its short-term obligations).
How much goodwill does Intelligent Bio Solutions have?
Intelligent Bio Solutions carried $2.8 million of goodwill and intangible assets, 23.4% of total assets, at the end of fiscal 2026.